Lombard Odier Asset Management (Switzerland)’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-31,942
| Closed | -$2.62M | – | 370 |
|
|
2022
Q3 | $2.62M | Sell |
31,942
-2,311
| -7% | -$189K | 0.22% | 101 |
|
|
2022
Q2 | $2.32M | Sell |
34,253
-17,484
| -34% | -$1.18M | 0.2% | 109 |
|
|
2022
Q1 | $5.72M | Sell |
51,737
-58,799
| -53% | -$6.5M | 0.45% | 61 |
|
|
2021
Q4 | $10.7M | Buy |
110,536
+9,349
| +9% | +$902K | 0.68% | 54 |
|
|
2021
Q3 | $8.83M | Buy |
101,187
+9,429
| +10% | +$823K | 0.55% | 66 |
|
|
2021
Q2 | $14.2M | Buy |
91,758
+36,446
| +66% | +$5.64M | 0.72% | 54 |
|
|
2021
Q1 | $8.73M | Buy |
+55,312
| New | +$8.73M | 0.58% | 59 |
|